Back

Predictors of major adverse cardiovascular events in patients with wild-type transthyretin amyloid cardiomyopathy: insights from a regional hospital experience

29 August 2025 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (1) - Cardiac amyloidosis (1) Infiltrative Myocardial Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Andre Martins

Leiria Hospital Centre, Leiria (Portugal)

9 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Mr S. Decotto (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Miss P. Domenech (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Assistant Professor A. Zaroui (Creteil, FR)
Abstract Slides Video
Presentation thumbnail
Doctor M. Maurer (New York, US)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (1) - Cardiac amyloidosis (1)

The Event

Event poster

ESC Congress 2025

29 August 2025 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Multimodality artificial intelligence-based major adverse cardiovascular events prediction in transthyretin amyloid cardiomyopathy patients
thumbnail
Congress Presentation
Predictors and outcomes of amyloid cardiomyopathy caused by transthyretin V30 mutation
thumbnail
Congress Presentation
The value of left atrio-ventricular coupling index (LACI) in transthyretin amyloidosis: insights from a cohort analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources